Levent Yazicioglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Levent Yazicioglu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Evren Ozcinar
Department of Cardiovascular Surgery, Ankara University, 06100 Ankara, Turkey
4 shared publications - Ahmet Kayan
Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, 06340 Ankara, Turkey
3 shared publications - Ahmet Rüçhan Akar
Department of Cardiovascular Surgery, Heart Center, Ankara University Faculty of Medicine, Cebeci Hospital, Ankara, Türkiye
3 shared publications - Cagdas Baran
Ankara University, Turkey (Türkiye)
3 shared publications - Mustafa Bahadir Inan
Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, 06340 Ankara, Turkey
3 shared publications - Ali Fuat Karacuha
Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey
2 shared publications
Latest Publications
- Open Access
- 9 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3298
Catheter-Directed Thrombolysis vs. Anticoagulation in Deep Vein Thrombosis: A Comparative Study
Background: Deep vein thrombosis (DVT) is an important component of venous thromboembolism and can lead to pulmonary embolism with high morbidity and mortality. Anticoagulant therapy alone (AC) and catheter-directed thrombolysis (CDT) are commonly used strategies for the management of DVT. Although CDT has been reported to be effective in reducing the risk of post-thrombotic syndrome (PTS), it remains unclear in which patient groups it should be preferred due to the risk of bleeding. Methods: This retrospective study included 175 patients diagnosed with DVT between 2015 and 2024 (98 AC, 77 CDT). Patients with a diagnosis of proximal DVT, aged ≥18 years, and with at least 30 days of follow-up data were included. The primary endpoint was 30-day mortality and secondary endpoints were the length of hospitalization, pulmonary embolism, and bleeding complications. Results: The CDT group was superior to AC in thrombus clearance rates, especially in iliac vein thrombosis (97.7% vs. 78%, p = 0.003). Clinical symptoms improved faster in the CDT group, but total hospitalization was longer. There were no significant differences in bleeding complications and mortality rates between the two groups. Conclusions: The optimal approach to DVT treatment should be based on the patient’s individual risk factors. Although CDT provides a higher thrombus clearance rate, especially in iliac vein thrombosis, it may not be suitable for all patients. Future large-scale studies will contribute to a better understanding of the long-term outcomes of interventional therapies.
- 9 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3298
Open AccessCatheter-Directed Thrombolysis vs. Anticoagulation in Deep Vein Thrombosis: A Comparative Study
Background: Deep vein thrombosis (DVT) is an important component of venous thromboembolism and can lead to pulmonary embolism with high morbidity and mortality. Anticoagulant therapy alone (AC) and catheter-directed thrombolysis (CDT) are commonly used strategies for the management of DVT. Although CDT has been reported to be effective in reducing the risk of post-thrombotic syndrome (PTS), it remains unclear in which patient groups it should be preferred due to the risk of bleeding. Methods: This retrospective study included 175 patients diagnosed with DVT between 2015 and 2024 (98 AC, 77 CDT). Patients with a diagnosis of proximal DVT, aged ≥18 years, and with at least 30 days of follow-up data were included. The primary endpoint was 30-day mortality and secondary endpoints were the length of hospitalization, pulmonary embolism, and bleeding complications. Results: The CDT group was superior to AC in thrombus clearance rates, especially in iliac vein thrombosis (97.7% vs. 78%, p = 0.003). Clinical symptoms improved faster in the CDT group, but total hospitalization was longer. There were no significant differences in bleeding complications and mortality rates between the two groups. Conclusions: The optimal approach to DVT treatment should be based on the patient’s individual risk factors. Although CDT provides a higher thrombus clearance rate, especially in iliac vein thrombosis, it may not be suitable for all patients. Future large-scale studies will contribute to a better understanding of the long-term outcomes of interventional therapies.
- Open Access
- 9 April 2025
- Published by MDPI AG in Preprints.org
Catheter-Mediated Selective Thrombolysis and Anticoagulant Therapy for Deep Vein Thrombosis: Analysis of Efficacy, Safety and Clinical Outcomes
Background. Deep vein thrombosis (DVT) is an important component of venous thromboembolism and can lead to pulmonary embolism with high morbidity and mortality. Anticoagulant therapy alone (ACA) and catheter-mediated thrombolysis (CDT) are commonly used strategies for the management of DVT. Although CDT has been reported to be effective in reducing the risk of postthrombotic syndrome (PTS), it remains unclear in which patient groups it should be preferred due to the risk of bleeding.Methods. This retrospective study included 175 patients diagnosed with DVT between 2015 and 2024 (98 ACA, 77 CDT). Patients with a diagnosis of proximal DVT, aged ≥18 years and with at least 30 days of follow-up data were included. The primary endpoint was 30-day mortality and secondary endpoints were length of hospitalization, pulmonary embolism and bleeding complications. Results. The CDT group was superior to ACA in thrombus clearance rates, especially in iliac vein thrombosis (97.7% vs. 78%, p=0.003). Clinical symptoms improved faster in the CDT group, but total hospitalization was longer. There were no significant differences in bleeding complications and mortality rates between the two groups.Conclusion. The optimal approach to DVT treatment should be based on the patient's individual risk factors. Although CDT provides a higher thrombus clearance rate, especially in iliac vein thrombosis, it may not be suitable for all patients. Future large-scale studies will contribute to a better understanding of the long-term outcomes of interventional therapies.
- 9 April 2025
- Published by MDPI AG in Preprints.org
Open AccessCatheter-Mediated Selective Thrombolysis and Anticoagulant Therapy for Deep Vein Thrombosis: Analysis of Efficacy, Safety and Clinical Outcomes
Background. Deep vein thrombosis (DVT) is an important component of venous thromboembolism and can lead to pulmonary embolism with high morbidity and mortality. Anticoagulant therapy alone (ACA) and catheter-mediated thrombolysis (CDT) are commonly used strategies for the management of DVT. Although CDT has been reported to be effective in reducing the risk of postthrombotic syndrome (PTS), it remains unclear in which patient groups it should be preferred due to the risk of bleeding.Methods. This retrospective study included 175 patients diagnosed with DVT between 2015 and 2024 (98 ACA, 77 CDT). Patients with a diagnosis of proximal DVT, aged ≥18 years and with at least 30 days of follow-up data were included. The primary endpoint was 30-day mortality and secondary endpoints were length of hospitalization, pulmonary embolism and bleeding complications. Results. The CDT group was superior to ACA in thrombus clearance rates, especially in iliac vein thrombosis (97.7% vs. 78%, p=0.003). Clinical symptoms improved faster in the CDT group, but total hospitalization was longer. There were no significant differences in bleeding complications and mortality rates between the two groups.Conclusion. The optimal approach to DVT treatment should be based on the patient's individual risk factors. Although CDT provides a higher thrombus clearance rate, especially in iliac vein thrombosis, it may not be suitable for all patients. Future large-scale studies will contribute to a better understanding of the long-term outcomes of interventional therapies.
- Open Access
- 17 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4179
Adverse Events in Open Surgical vs. Ultrasound-Guided Percutaneous Brachial Access for Endovascular Interventions
Background: Advances in endovascular interventions have made endovascular approaches the first option for treating peripheral arterial diseases. Although radial artery access is commonly used for coronary procedures, the common femoral artery remains the most frequent site for endovascular treatments due to better ergonomics and proven technical success. Meanwhile, data on using upper extremity access via the brachial artery during complex endovascular aortic interventions are lacking. This study aimed to compare the incidence of access site complications between ultrasound-guided percutaneous brachial access (UPA) and open surgical incisional brachial access (OSA) in the management of peripheral arterial diseases. Methods: Patients who underwent treatment for peripheral arterial and aortic disease using brachial access from 2019 to 2023 were included in this study. The primary endpoint was the complication rate at the access site 30 days postoperatively. Access-related complications included bleeding requiring re-exploration, acute upper limb ischemia, thrombosis, pseudoaneurysm, arteriovenous fistula, and nerve injury associated with the brachial access. Results: Brachial access was performed on 485 patients (UPA, n = 320; OSA, n = 165). The mean operation time was 164.5 ± 45.4 min for the percutaneous procedure and 289.2 ± 79.4 min for the cutdown procedure (p = 0.003). Postprocedural hematoma occurred in 15 patients in the UPA group and 2 patients in the OSA group (p = 0.004). Thromboembolic events were observed in 9 patients in the percutaneous group and 3 patients in the OSA group. Reoperation was required for 23 patients in the percutaneous group and 8 patients in the cutdown group. Conclusions: The findings indicate that patients undergoing endovascular arterial interventions have a higher rate of brachial access complications in the UPA group compared to the OSA group.
- 17 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4179
Open AccessAdverse Events in Open Surgical vs. Ultrasound-Guided Percutaneous Brachial Access for Endovascular Interventions
Background: Advances in endovascular interventions have made endovascular approaches the first option for treating peripheral arterial diseases. Although radial artery access is commonly used for coronary procedures, the common femoral artery remains the most frequent site for endovascular treatments due to better ergonomics and proven technical success. Meanwhile, data on using upper extremity access via the brachial artery during complex endovascular aortic interventions are lacking. This study aimed to compare the incidence of access site complications between ultrasound-guided percutaneous brachial access (UPA) and open surgical incisional brachial access (OSA) in the management of peripheral arterial diseases. Methods: Patients who underwent treatment for peripheral arterial and aortic disease using brachial access from 2019 to 2023 were included in this study. The primary endpoint was the complication rate at the access site 30 days postoperatively. Access-related complications included bleeding requiring re-exploration, acute upper limb ischemia, thrombosis, pseudoaneurysm, arteriovenous fistula, and nerve injury associated with the brachial access. Results: Brachial access was performed on 485 patients (UPA, n = 320; OSA, n = 165). The mean operation time was 164.5 ± 45.4 min for the percutaneous procedure and 289.2 ± 79.4 min for the cutdown procedure (p = 0.003). Postprocedural hematoma occurred in 15 patients in the UPA group and 2 patients in the OSA group (p = 0.004). Thromboembolic events were observed in 9 patients in the percutaneous group and 3 patients in the OSA group. Reoperation was required for 23 patients in the percutaneous group and 8 patients in the cutdown group. Conclusions: The findings indicate that patients undergoing endovascular arterial interventions have a higher rate of brachial access complications in the UPA group compared to the OSA group.
- Open Access
- 9 August 2012
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 7 (1) , 73
The efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting
Coronary artery bypass grafting (CABG) with cardioplegic cardiac arrest and cardiopulmonary bypass (CPB) is associated with myocardial injury. The aim of this study was to investigate whether a modified mechanical post-conditioning (MMPOC) technique has a myocardial protective effect by enhancing early metabolic recovery of the heart following revascularization.
- 9 August 2012
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 7 (1) , 73
Open AccessThe efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting
Coronary artery bypass grafting (CABG) with cardioplegic cardiac arrest and cardiopulmonary bypass (CPB) is associated with myocardial injury. The aim of this study was to investigate whether a modified mechanical post-conditioning (MMPOC) technique has a myocardial protective effect by enhancing early metabolic recovery of the heart following revascularization.